首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   109553篇
  免费   11163篇
  国内免费   8099篇
耳鼻咽喉   933篇
儿科学   1375篇
妇产科学   697篇
基础医学   9569篇
口腔科学   1783篇
临床医学   13602篇
内科学   12544篇
皮肤病学   922篇
神经病学   4516篇
特种医学   4456篇
外国民族医学   39篇
外科学   11322篇
综合类   25265篇
现状与发展   23篇
一般理论   16篇
预防医学   10104篇
眼科学   2071篇
药学   13051篇
  138篇
中国医学   8981篇
肿瘤学   7408篇
  2024年   512篇
  2023年   1620篇
  2022年   4004篇
  2021年   5023篇
  2020年   4224篇
  2019年   2874篇
  2018年   3107篇
  2017年   3365篇
  2016年   2894篇
  2015年   4863篇
  2014年   6184篇
  2013年   6597篇
  2012年   9547篇
  2011年   10450篇
  2010年   8185篇
  2009年   6946篇
  2008年   7461篇
  2007年   7249篇
  2006年   6689篇
  2005年   5807篇
  2004年   4072篇
  2003年   3476篇
  2002年   2877篇
  2001年   2381篇
  2000年   2023篇
  1999年   1371篇
  1998年   802篇
  1997年   770篇
  1996年   612篇
  1995年   540篇
  1994年   412篇
  1993年   303篇
  1992年   251篇
  1991年   200篇
  1990年   193篇
  1989年   188篇
  1988年   139篇
  1987年   135篇
  1986年   111篇
  1985年   98篇
  1984年   49篇
  1983年   35篇
  1982年   34篇
  1981年   24篇
  1980年   15篇
  1979年   17篇
  1978年   7篇
  1972年   6篇
  1959年   6篇
  1958年   8篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
991.
目的探讨miR-21对骨质疏松小鼠骨髓基质细胞(BMSCs)增殖的影响。方法采用双侧卵巢切除法构建骨质疏松小鼠模型(VOX),分离、培养、纯化小鼠BMSCs并采用si PORT Neo FX转染pre-miR-21、pre-miR-negative control(pre-miR-NC)、antmiR-21、ant-miR-negative control(ant-miR-NC)并进行RT-PCR验证,MTT法检测小鼠BMSCs增殖情况、茜素红与碱性磷酸酶染色法检测小鼠BMSCs成骨能力、Western-blotting检测细胞增殖、成骨分化相关蛋白水平。结果骨质疏松症小鼠BMSCs中miR-21相对表达水平低于Ctrl组(P0.05),OVX-pre-miR-21组BMSCs中miR-21相对表达水平、细胞增殖、PCNA水平、Ki-67水平、ALP染色程度、ALP活性、茜素红染色程度、Runx2水平、Osterix水平均高于OVX-pre-miR-NC组(P0.05),OVX-premiR-NC组BMSCs中miR-21相对表达水平、细胞增殖、PCNA水平、Ki-67水平、ALP染色程度、ALP活性、茜素红染色程度、Runx2水平、Osterix水平均显著低于Ctrl-pre-miR-NC(P0.05); OVX-ant-miR-21组BMSCs中miR-21相对表达水平、细胞增殖、PCNA水平、Ki-67水平、ALP染色程度、ALP活性、茜素红染色程度、Runx2水平、Osterix水平均显著低于OVX-ant-miR-NC组(P0.05),OVX-ant-miR-NC组BMSCs中miR-21相对表达水平、细胞增殖、PCNA水平、Ki-67水平、ALP染色程度、ALP活性、茜素红染色程度、Runx2水平、Osterix水平均显著低于Ctrl-ant-miR-NC(P0.05)。结论提高miR-21表达水平可促进骨质疏松小鼠BMSCs增殖能力与成骨分化能力。  相似文献   
992.
993.
Sternal wound infection (SWI) is a devastating complication after cardiac surgery. Platelet‐rich plasma (PRP) may have a positive impact on sternal wound healing. A systematic review with meta‐analyses was performed to evaluate the clinical effectiveness of topical application of autologous PRP for preventing SWI and promoting sternal wound healing compared to placebo or standard treatment without PRP. Relevant studies published in English or Chinese were retrieved from the Cochrane Central Register of Controlled Trials (The Cochrane Library), PubMed, Ovid EMBASE, Web of Science, Springer Link, and the WHO International Clinical Trials Registry Platform (ICTRP) using the search terms “platelet‐rich plasma” and “sternal wound” or “thoracic incision.” References identified through the electronic search were screened, the data were extracted, and the methodological quality of the included studies was assessed. The meta‐analysis was performed for the following outcomes: incidence of SWI, incidence of deep sternal wound infection (DSWI), postoperative blood loss (PBL), and other risk factors. In the systematic review, totally 10 comparable studies were identified, involving 7879 patients. The meta‐analysis for the subgroup of retrospective cohort studies (RSCs) showed that the incidence of SWI and DSWI in patients treated with PRP was significantly lower than that in patients without PRP treatment. However, for the subgroup of randomized controlled trials (RCTs), there was no significant difference in the incidence of SWI or DSWI after intervention between the PRP and control groups. There was no significant difference in PBL in both RCTs and RSCs subgroups. Neither adverse reactions nor in‐situ recurrences were reported. According to the results, PRP could be considered as a candidate treatment to prevent SWI and DSWI. However, the quality of the evidence is too weak, and high‐quality RCTs are needed to assess its efficacy on preventing SWI and DSWI.  相似文献   
994.
Bai  Shilei  Yang  Pinghua  Xie  Zhihao  Li  Jun  Lei  Zhengqing  Xia  Yong  Qian  Guojun  Zhang  Baohua  Pawlik  Timothy M.  Lau  Wan Yee  Shen  Feng 《Annals of surgical oncology》2021,28(13):8174-8185
Annals of Surgical Oncology - The aim of this study was to examine prognostic differences between liver resection (LR) and percutaneous radiofrequency ablation (PRFA) for hepatocellular carcinoma...  相似文献   
995.
Context: Osteochondroma is the most common benign tumor of the bone, but spinal osteochondroma is rare. We report a case of cervical osteochondroma in multiple exostoses arising from the lamina of the C2 vertebra, presenting with features of compressive myelopathy in a 22-year-old male. Total resection of the tumor and atlantoaxial fixation and fusion after reconstruction of the C1 posterior arch were performed.Findings: The patient recovered significantly. He was asymptomatic and no sign of recurrence was observed after one-year follow-up.Conclusions: Osteochondroma should be considered as a rare cause of spinal cord compression. Entire removal of the tumor will result in complete decompression and can reduce the risk of recurrence. We provide a new approach to reconstruct after resection.  相似文献   
996.
Clinical and Experimental Nephrology - Complex molecular cell dynamics in acute kidney injury and its heterogeneous etiologies in patient populations in clinical settings have revealed the...  相似文献   
997.
998.
载药微球经导管动脉化疗栓塞(DEB-TACE)利用微球在靶病灶内释放化学治疗(简称化疗)药物,使靶肿瘤内药物浓度更高,而全身化疗药物浓度及不良反应降低;且微球可较完全栓塞肿瘤毛细血管网,闭塞肿瘤邻近血管,致癌细胞缺血、缺氧而坏死。本文对DEB-TACE治疗肝细胞癌(HCC)研究进展进行综述。  相似文献   
999.
侧方淋巴引流是低位直肠癌3个重要的淋巴引流方向之一。沿引流途径清扫淋巴结是直肠癌根治术基本要求,也决定淋巴结清扫范围。但侧方淋巴结是区域淋巴结还是远处淋巴结,一直存在争议。这带来新辅助放化疗和侧方淋巴结清扫、以及新辅助放化疗对侧方淋巴结转移疗效的争议。笔者综合分析国内外研究进展,对直肠癌侧方淋巴结转移规律、影响侧方淋巴结转移复发危险因素以及放化疗前后MRI检查对侧方淋巴结评估等进行深入阐述,并结合临床实践,探讨进展期低位直肠癌新辅助放化疗后侧方淋巴结清扫的选择和意义。  相似文献   
1000.
Bulletin of Environmental Contamination and Toxicology - The hydraulic conductivity of Na-montmorillonite in dual-cation solutions of Na+ and Mn+ (Mn+ = K+, Ca2+, Zn2+ and Al3+) with a constant...  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号